Tusamitamab-MMAE (ADC)
Tusamitamab-MMAE is an ADC consisting of a CEACAM5-directed antibody and Monomethyl auristatin E (MMAE) used for the study of non-small cell lung cancer.
Product Specifications
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
More Discoveries
Explore Other Products
Browse additional items from our catalog
302360-ML405 100 µL
CMAS (N-acylneuraminate cytidylyltransferase, CMP-N-acetylneuraminic Acid Synthase, CMP-NeuNAc Synthase, CMAS) (MaxLight 405) discontinued
Sign In for Pricing
View Details OR1039029-01 100 mg
2- (6-Methoxy-2,3-dihydrobenzofuran-3-yl) acetic acid
Sign In for Pricing
View Details 
OR1039029-02 250 mg
2- (6-Methoxy-2,3-dihydrobenzofuran-3-yl) acetic acid
Sign In for Pricing
View Details OR1039029-03 1 g
2- (6-Methoxy-2,3-dihydrobenzofuran-3-yl) acetic acid
Sign In for Pricing
View Details